跳至主要内容
临床试验/CTRI/2023/07/054894
CTRI/2023/07/054894尚未招募3 期

Evaluation of efficacy of Hydroxychloroquine as an add-on therapy to antithyroid drugs in the treatment of Graves disease: A Pilot study - Not Applicable

IPQA laboratories0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with newly diagnosed Graveâ??s disease with serum total T4 levels more than 20 microgram/dl.

排除标准

  • 1. Pregnant and lactating women
  • 2. Patients on corticosteroids or immunosuppressive drugs
  • 3. Patients in whom the use of hydroxychloroquine is contraindicated.

研究者

发起方
IPQA laboratories

相似试验

Efficacy of hydroxychloroquine in graves disease in... | 临床试验